NRAS and melanoma: Figure 2h illustrates the MAPK pathway-related mechanisms facilitating sustained cell survival in NRAS-mutant melanoma, while Fig. 2i illustrates the antiproliferative effects of NRAS ASO treatment, and inhibition of the MAPK signaling stream.